Overview

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

Status:
Terminated
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether GTx 758 is effective in achieving and maintaining castrate testosterone levels in men with advanced prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
GTx
Treatments:
Hormones
Leuprolide
Methyltestosterone
Prolactin Release-Inhibiting Factors
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate